Adrianna Mendrek

Dr. Adrianna Mendrek


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
AMAdrianna Mendrek
Adrianna Mendrek
AMAdham Mancini-Marïe
Adham Mancini-Marïe

1 April 2015 in Biological Psychiatry
Verified
Journal Article
Closed access
RJRobert-Paul Juster
Robert-Paul Juster
MHMark L. Hatzenbuehler
Mark L. Hatzenbuehler
AMAdrianna Mendrek
Adrianna Mendrek
JPJames G. Pfaus, PhD
James G. Pfaus, PhD
NSNathan Grant Smith
Nathan Grant Smith
JPJens C. Pruessner
Jens C. Pruessner

1 December 2015 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
OLOvidiu Lungu
Ovidiu Lungu
SPStéphane Potvin
Stéphane Potvin
ATAndràs Tikàsz
Andràs Tikàsz
AMAdrianna Mendrek
Adrianna Mendrek

1 July 2011 in Expert Review of Neurotherapeutics
Verified
Journal Article
Closed access
AMAdrianna Mendrek
Adrianna Mendrek
ESEmmanuel Stip
Emmanuel Stip
Gender differences have been reported in various aspects of schizophrenia, including its epidemiology, clinical course and the response to antipsychotic medications. Over the past few years the authors have been investigating sex differences in brain function in individuals with schizophrenia and have found an intriguing disturbance of normal sexual dimorphism during emotional and cognitive processing. These results can be partly accounted for by altered levels of sex steroid hormones (i.e., estrogen and testosterone) in patients. A handful of clinical research groups have tried low doses of estrogen, testosterone or their precursors as adjunct therapies to the currently available antipsychotic medications in women and men with schizophrenia. The results have been promising, but further investigation is warranted. In the future, new more specific steroidal compounds will be developed and we will see more studies examining sex differences in the brain, behavior and mental health problems. This research will help to identify individuals who may benefit greatest from adjunct hormonal therapies and will further our understanding of the etiology of schizophrenia and other psychiatric disorders.

19 June 2012 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
ESEmmanuel Stip
Emmanuel Stip
OLO V Lungu
O V Lungu
KAK Anselmo
K Anselmo
GLG Letourneau
G Letourneau
AMAdrianna Mendrek
Adrianna Mendrek
LBL A Bentaleb
L A Bentaleb
There is evidence that some atypical antipsychotics, including olanzapine, can produce unwanted metabolic side effects, weight gain and diabetes. However, neuronal correlates of change related to food information processing have not been investigated with these medications. We studied the effect of a pharmacological manipulation with an antipsychotic known to cause weight gain on metabolites, cognitive tasks and neural correlates related to food regulation. We used functional magnetic resonance imaging in conjunction with a task requiring visual processing of appetitive stimuli in schizophrenic patients and healthy controls before and after 16 weeks of antipsychotic medication with olanzapine. In patients, the psychological and neuronal changes associated following the treatment correlated with appetite control measures and metabolite levels in fasting blood samples. After 16 weeks of olanzapine treatment, the patients gained weight, increased their waist circumference, had fewer positive schizophrenia symptoms, a reduced ghrelin plasma concentration and an increased concentration of triglycerides, insulin and leptin. In premotor area, somatosensory cortices as well as bilaterally in the fusiform gyri, the olanzapine treatment increased the neural activity related to appetitive information in schizophrenic patients to similar levels relative to healthy individuals. However, a higher increase in sensitivity to appetitive stimuli after the treatment was observed in insular cortices, amygdala and cerebellum in schizophrenic patients as compared with healthy controls. Furthermore, these changes in neuronal activity correlated with changes in some metabolites and cognitive measurements related to appetite regulation.

24 February 2021 in Current Psychology
Verified
Journal Article
Closed access
PDF file
DLD. Lambert
D. Lambert
NBN. H. van Den Berg
N. H. van Den Berg
AMAdrianna Mendrek
Adrianna Mendrek